Dr. Asquith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
215 N 28th Ave
Wausau, WI 54401Phone+1 715-847-2866
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2017 - 2020
Ohio State University HospitalResidency, Internal Medicine/Pediatrics, 2012 - 2016
St. George's University School of MedicineClass of 2012
University of FloridaBS, Microbiology , 2001 - 2005
Certifications & Licensure
WI State Medical License 2020 - 2025
FL State Medical License 2017 - 2021
OH State Medical License 2012 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 60 citationsA feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.Gang Chen, Richa Gupta, Silvia Petrik, Marina Laiko, James M. Leatherman
Cancer Immunology Research. 2014-10-01 - 171 citationsTimed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Che...Leisha A. Emens, Justin M. Asquith, James M. Leatherman, Barry Kobrin, Silvia Petrik
Journal of Clinical Oncology. 2009-12-10 - 158 citationsA vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.Elizabeth A. Manning, John G.M. Ullman, James M. Leatherman, Justin M. Asquith, Timothy R. Hansen
Clinical Cancer Research. 2007-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
